Pano Koumantaros Cancer Research Fund Inc
- Assets
- $538.9k
- Revenue
- $115.5k
- Investments
- $460.6k
- Employees
- 0
- Location
- Tacoma, WA
- Founding
- 09/2015
- Data as of
- 12/2022
- EIN
- 47-2592539
Organization Overview
Pano Koumantaros Cancer Research Fund Inc is located in Tacoma, WA. The organization was established in 2015. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pano Koumantaros Cancer Research Fund Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Pano Koumantaros Cancer Research Fund Inc generated $115.5k in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 29.9% each year . All expenses for the organization totaled $74.9k during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
MARY BRIDGE CHILDRENS HOSPITAL
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Maria Koumantaros President | 2 | $0 | |
Kevin Boercker Treasurer/se | 1 | $0 | |
Petros Koumantaros Vice Preside | 1 | $0 | |
Yannis Koumantaros Vice Preside | 1 | $0 | |
Liz Truong Executive Di | 30 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $350 |
| Interest on Savings | $0 |
| Dividends & Interest | $9,724 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $9,675 |
| Capital Gain Net Income | $9,675 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $95,746 |
| Total Revenue | $115,495 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $43,515 |
| Total operating and administrative expenses | $74,893 |
| Contributions, gifts, grants paid | $0 |
| Total expenses and disbursements | $74,893 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $60,457 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $17,908 |
| Total assets | $538,928 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
Grants Awarded
Over the last fiscal year, Pano Koumantaros Cancer Research Fund Inc has awarded $141,221 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
MARY BRIDGE CHILDRENS HOSPITAL PURPOSE: CANCER RESEARCH | $96,211 |
CAMP AGAPE NORTHWEST PURPOSE: CANCER RESEARCH | $30,000 |
THE GOODTIMES PROJECT PURPOSE: CANCER RESEARCH | $10,010 |
CANCER PATHWAYS PURPOSE: CANCER RESEARCH | $5,000 |